Market size, growth to 2033 and clinical trials, side by side.
China is the bigger Anti-Snoring Devices market: $101 Mn against $23 Mn in 2023, about 4.4 times as large.
India grows faster: 11.8% a year, against 10.3%. The gap still grows from $78 Mn to $198 Mn by 2033.
Clinical research: 16 active trials in China, 1 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $101 Mn | $23 Mn |
| Market size, 2033 projected | $268 Mn | $69 Mn |
| Growth a year (CAGR) | 10.3% | 11.8% |
| Money added, 2023–2033 | $167 Mn | $47 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.07 | $0.02 |
| Active clinical trials | 16 | 1 |
| Full report | China report | India report |
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
China is the bigger Anti-Snoring Devices market: $101 Mn against $23 Mn in 2023, about 4.4 times as large.
India grows faster: 11.8% a year, against 10.3%. The gap still grows from $78 Mn to $198 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.